The decision to pursue one's desire for children is a basic human right. For transgender and
gender-diverse (TGD) people, gender-affirming care may alter the possibilities to fulfill one's …

Survival rates for children and adolescents diagnosed with malignancy have been steadily
increasing due to advances in oncology treatments. These treatments can have a toxic effect …

Oocyte cryopreservation (OC) is the process in which ovarian follicles are stimulated, the
follicular fluid is retrieved, and mature oocytes are isolated and vitrified. Since the first …

Objective To describe family planning and fertility counseling perspectives of reproductive-
age gender diverse adults and youth pursuing gender affirming hormone therapy. Materials …

Testosterone gender affirming hormone therapy (T-GAHT) is frequently used by transgender
and gender-diverse individuals assigned female at birth to establish masculinizing …

Background: Transgender and non-binary individuals face unique challenges when it
comes to fertility preservation (FP). Objective: Despite the growing prevalence of gender …

It is estimated that over 1.6 million adults and adolescents identify as transgender or gender
diverse in the United States, representing 0.6% of the population. 1 Extrapolating similar …

Objective To evaluate fertility treatment outcomes among transgender (TG) men with a
history of gender-affirming hormone therapy with exogenous testosterone. Design …

Medical care for transgender people is multi-faceted and attention to individual reproductive
aspirations and planning are an essential, yet often overlooked aspect of care. Given the …

LGBTQ+ women have long been overlooked in sexual and reproductive health research.
However, recent research has established that LGBTQ+ women have unique and specific …